ClinicalTrials.gg
CompletedNCT04457622LaBRhythmsUpdated Aug 20, 2026

Language and Brain Rhythms

An interventional study of Auditory perception tasks in healthy participants in Healthy Volunteers, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
264
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Study summary

For humans and other animals, predicting the timing of sensory events is essential for their daily behavior. Importantly, natural sensory stimulation (such as movements, music, or speech) can present temporal regularities allowing for temporal prediction of incoming sensory information. For instance, individuals can easily predict in time the next step of a walker, or the next beat of a song based on the rhythm. The phenomenon of temporal prediction has for now only been investigated experimentally in deterministic scenarios, i.e. when the duration between two sensory events is fixed, or when stimuli present a regular beat. The objective of this project is to understand how we process more natural, hence more complex forms of temporal regularities, and how individuals make inferences on the timing of sensory events based on past temporal statistics of sensory information. This is particularly important for speech processing, considering that speech is an acoustic signal that is known to possess some form of temporal regularity, and yet is not purely rhythmic nor does have a deterministic temporal structure. Temporal regularities are specific to each spoken language, and both native and non-native language listeners are known to use temporal acoustic cues during speech listening. This affects speech comprehension and has a strong impact during language learning. Hence, understanding the processing of temporal regularities in speech can help improve language abilities in first and second language learners.

The project is composed of four experiments. The first behavioral experiment will investigate how auditory perception is affected by the temporal statistics of past sensory information using artificial stimuli. The second axis will investigate the neural mechanisms underlying auditory timing processing with electroencephalography (EEG). The last Magnetoencephalography (MEG, experiment 3) and EG (rxperiement 4) experiment will test the role of temporal statistics in an ecological setting, namely speech listening. The project will thus provide strong theoretical advances as it will give new insights on brain mechanisms for the processing of complex temporal information in audition and speech, and their role in language comprehension. It will also provide methodological advances. Specifically, the project will contribute to the development and validation of cutting-edge methods in MEG. Namely, it will aim at creating new tools to investigate the neural correlates of auditory and speech processing with an unprecedented temporal and spatial resolution.

02

Conditions studied

  • Healthy Volunteers

Browse trials for

Keywords

  • Auditory Perception
  • Speech
  • Neuroimaging
03

In context

Speech

205 studies on the registry are indexed under Speech; 80 are open to participants now.

This study's enrollment of 264 is above the median of 52 across 141 interventional studies indexed under Speech.

Browse Speech studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For all experiments:

  • 18- 40 years old
  • Registration with the French healthcare system
  • Normal hearing

Additionally, for experiments 2,3 and 4 :

- Right handed

Additionally, for experiment 3 and 4:

- French as native language

Exclusion criteria

Exclusion Criteria:

For All Experiments:

  • Neurological or psychiatric illnesses or a history of such problems that could impact quality/variability of data or cooperation and retention of the subject in the study
  • Regular use of medications that impact the central nervous system
  • Regular use of medications, such as opioids and antidepressants, including SSRIs and tricyclic antidepressants
  • Severe hearing loss
  • A history of stroke or recent trauma to the head
  • Persons unable to adhere to abstinence from the use of drugs or alcohol the day or evening before experimental sessions
  • Women who are pregnant, breastfeeding, or have given birth in the last 6 months

Additionally, for experiment 2,3 and 4 :

  • A pacemaker, insulin or other pump, neurostimulator, cochlear implants or other hearing aid, metal stents, prosthesis, or implants, intracerebral clips, implantable defibrillator, cerebral shunt or ventricular catheter, other foreign metal objects in the upper part of the body
  • any dental apparatus containing metal including or root canals
  • any foreign metallic object anywhere in the body
  • bolts, screws
  • orthopedic devices or implants

Additionally, for experiment 3 and 4:

  • claustrophobia
  • glasses (given the participant cannot use contact lenses)
  • a head size incompatible with the use of a personalized 3D headcast or a magnetoencephalography
  • Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
264 participants (actual)

Study arms

  • Experimental
    Main study group

    All participants signed up for experiment 1, 2, 3 or 4 complete the same protocol (1 study arm) with an intent for intra-subject correlational analyses

    Other: Auditory perception tasks in healthy participants

Interventions

  • OtherAuditory perception tasks in healthy participants

    The participants complete auditory perception tasks while EEG, and MEG record brain signals (primary outcome measure). The tasks acquire behavioral responses with button presses (secondary outcome measure). All analyses are intra-subject (no analyses are between-subject).

06

What researchers measure

Primary outcomes

  1. Stimulus-Brain (EEG) Coherence in the delta-theta range (1 Hz - 8 Hz)

    Time frame: at max 90 days

  2. Amplitude of EEG evoked responses to the target stimuli

    Time frame: at max 90 days

  3. Stimulus-Brain (MEG) Coherence in the delta-theta range (1 Hz - 8 Hz)

    Time frame: at max 90 days

  4. Amplitude of MEG evoked responses to the target stimuli

    Time frame: at max 90 days

Secondary outcomes

  1. Percentage of correct responses

    The secondary outcome measures will be recorded in all experiments

    Time frame: at max 90 days

  2. Response Times

    The secondary outcome measures will be recorded in all experiments

    Time frame: at max 90 days

07

Study locations

1 site
  • Centre de Recherche en Neuroscience de Lyon
    Bron, 69500, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2021 to primary completion in Mar 2026, 60 months.

Of 85 non-industry interventional studies with no phase under Speech, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 65. This study's 60 months is above that.

Counting every sponsor, half of 90 studies reached it within 45 months; a quarter within 15 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2020
First posted
Jul 7, 2020
StartActual
Feb 18, 2021
Primary completionActual
Mar 16, 2026
CompletionActual
Mar 16, 2026
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04457622
Responsible party
Sponsor
First posted
Jul 7, 2020
Start date
Feb 18, 2021
Primary completion
Mar 16, 2026
Completion
Mar 16, 2026
Last update
Aug 20, 2026

Study contacts

Anne KOSEM, PhD
principal investigator · Centre de recherche de Neurosciences de Lyon (CRNL)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion